Wenxin Zheng

VEGF expression and enhanced production by gonadotropins in ovarian epithelial tumors.

Effect of reproductive hormones on ovarian epithelial tumors: I. Effect on cell cycle activity.

Effect of reproductive hormones on ovarian epithelial tumors: II. Effect on angiogenic activity.

Quantitative analysis of follicle-stimulating hormone receptor in ovarian epithelial tumors: a novel approach to explain the field effect of ovarian cancer development in secondary mullerian systems.

Inhibin immunohistochemical staining: a practical approach for the surgical pathologist in the diagnoses of ovarian sex cord-stromal tumors.

Mechanisms involved in the evolution of progestin resistance in human endometrial hyperplasia--precursor of endometrial cancer.

Low-grade endometrial stromal sarcoma: hormonal aspects.

Neoadjuvant chemotherapy for advanced ovarian cancer: the role of cytology in pretreatment diagnosis.

Regulation of PTEN (phosphatase and tensin homolog deleted on chromosome 10) expression by estradiol and progesterone in human endometrium.

Microsatellite instability and expression of hMLH1 and hMSH2 proteins in ovarian endometrioid cancer.

Involution of PTEN-null endometrial glands with progestin therapy.

Microsatellite instability and alteration of the expression of hMLH1 and hMSH2 in ovarian clear cell carcinoma.

Endometrial glandular dysplasia: a newly defined precursor lesion of uterine papillary serous carcinoma. Part I: morphologic features.

Inhibin expression in ovarian-type stroma in mucinous cystic neoplasms of the pancreas.

OCT4: a novel biomarker for dysgerminoma of the ovary.

HER2 protein (p185(HER2)) is only rarely overexpressed in cervical cancer.

Eosinophilic dysplasia of the cervix: a newly recognized variant of cervical squamous intraepithelial neoplasia.

Endometrial glandular dysplasia: a putative precursor lesion of uterine papillary serous carcinoma. Part II: molecular features.

Expression of interleukin-8 receptors in endometriosis.

Age dependent association of endometrial polyps with increased risk of cancer involvement.

Serous EIC as an early form of uterine papillary serous carcinoma: recent progress in understanding its pathogenesis and current opinions regarding pathologic and clinical management.

Histologic dating of the endometrium: accuracy, reproducibility, and practical value.

Overexpression of osteopontin in rheumatoid synovial mononuclear cells is associated with joint inflammation, not with genetic polymorphism.

Role of osteopontin in amplification and perpetuation of rheumatoid synovitis.

Initial endometriosis showing direct morphologic evidence of metaplasia in the pathogenesis of ovarian endometriosis.

E-Cadherin and beta-Catenin expression in early stage cervical carcinoma: a tissue microarray study of 147 cases.

Expression of interleukin-8 and monocyte chemotactic protein-1 in adenomyosis.

Expression of CD117 (c-kit) receptor in dysgerminoma of the ovary: diagnostic and therapeutic implications.

Well-differentiated papillary villoglandular adenocarcinoma of the uterine cervix with a focal high-grade component: is there a need for reassessment?

[Study on extraction of zhuyun 3# by supercritical CO2].

Correlation of tumor phenotype with c-fms proto-oncogene expression in an in vivo intraperitoneal model for experimental human breast cancer metastasis.

A 44-year-old woman with menometrorrhagia.

Expression of interleukin-8 receptors in patients with adenomyosis.

Chromosome 12p abnormalities in dysgerminoma of the ovary: a FISH analysis.

A high-grade uterine leiomyosarcoma with human chorionic gonadotropin production.

Cytokeratin and CD30 expression in dysgerminoma.

PGR +331 A/G and increased risk of epithelial ovarian cancer.

Precursors of endometrial clear cell carcinoma.

Occurrence of endometrial glandular dysplasia precedes uterine papillary serous carcinoma.

Membrane proteome analysis of microdissected ovarian tumor tissues using capillary isoelectric focusing/reversed-phase liquid chromatography-tandem MS.

Haploinsufficiency of the cdc2l gene contributes to skin cancer development in mice.

Carcinomas of ovary and lung with clear cell features: can immunohistochemistry help in differential diagnosis?

Sertoliform endometrioid carcinoma of the endometrium with dual immunophenotypes for epithelial membrane antigen and inhibin alpha: case report and literature review.

Variations of mitotic index in normal and dysplastic squamous epithelium of the uterine cervix as a function of endometrial maturation.

Molecular genetic evidence supporting the neoplastic nature of the Leydig cell component of ovarian Sertoli-Leydig cell tumors.

Endometrial glandular dysplasia and endometrial intraepithelial neoplasia.

The oncofetal protein IMP3: a novel biomarker for endometrial serous carcinoma.

Endometrial Glandular Dysplasia (EmGD): morphologically and biologically distinctive putative precursor lesions of Type II endometrial cancers.

Expression of interleukin-8 and monocyte chemotactic protein 1 in women with endometriosis.

Endometrial glandular dysplasia with frequent p53 gene mutation: a genetic evidence supporting its precancer nature for endometrial serous carcinoma.

Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2.

Histopathology of endometrial hyperplasia and endometrial carcinoma. An update by Dr LC Horn et al in Annals of Diagnostic Pathology 2007;11:297-311.

Overexpression of follicle-stimulating hormone receptor facilitates the development of ovarian epithelial cancer.

HuR expression in the nucleus correlates with high histological grade and poor disease-free survival in ovarian cancer.

Aberrant survivin expression in endometrial hyperplasia: another mechanism of progestin resistance.

Insights into endometrial serous carcinogenesis and progression.

Molecular identification of "latent precancers" for endometrial serous carcinoma in benign-appearing endometrium.

Role of osteopontin in induction of monocyte chemoattractant protein 1 and macrophage inflammatory protein 1beta through the NF-kappaB and MAPK pathways in rheumatoid arthritis.

Targeting glucosylceramide synthase downregulates expression of the multidrug resistance gene MDR1 and sensitizes breast carcinoma cells to anticancer drugs.

Personal history of breast cancer as a significant risk factor for endometrial serous carcinoma in women aged 55 years old or younger.

High levels of Nrf2 determine chemoresistance in type II endometrial cancer.

A proposed model for endometrial serous carcinogenesis.

[Opinions about diagnosis and treatment of cervical cancer and its precancerous lesions in China].

Nrf2 expression in endometrial serous carcinomas and its precancers.

Serous endometrial intraepithelial carcinoma arising in adenomyosis: a report of 5 cases.

KIT gene mutation and amplification in dysgerminoma of the ovary.

Tubal origin of 'ovarian' low-grade serous carcinoma.

Ovarian serous carcinoma: recent concepts on its origin and carcinogenesis.

Fallopian tube as main source for ovarian and pelvic (non-endometrial) serous carcinomas.

Endometrial serous carcinoma (uterine papillary serous carcinoma): precancerous lesions and the theoretical promise of a preventive approach.

Rapamycin synergizes with low-dose oxaliplatin in the HCT116 colon cancer cell line by inducing enhanced apoptosis.

Detection of PAX8 and p53 is beneficial in recognizing metastatic carcinomas in pelvic washings, especially in cases with suspicious cytology.

Morphologic and other clinicopathologic features of endometrial clear cell carcinoma: a comprehensive analysis of 50 rigorously classified cases.

Struma ovarii simulating ovarian sertoli cell tumor: a case report with literature review.

Expression of the oncofetal protein IGF2BP3 in endometrial clear cell carcinoma: assessment of frequency and significance.

The clinicopathologic significance of p53 and BAF-250a (ARID1A) expression in clear cell carcinoma of the endometrium.

Lynch syndrome related endometrial cancer: clinical significance beyond the endometrium.

Sam68 modulates the promoter specificity of NF-κB and mediates expression of CD25 in activated T cells.

PAX8: a sensitive and specific marker to identify cancer cells of ovarian origin for patients prior to neoadjuvant chemotherapy.

Secretory cell expansion with aging: risk for pelvic serous carcinogenesis.

Utility of α-methylacyl-coenzyme-A racemase (p504s) immunohistochemistry in distinguishing endometrial clear cell carcinomas from serous and endometrioid carcinomas.

Cytologic changes of ovarian epithelial cancer induced by neoadjuvant chemotherapy.

Frequent expression of napsin A in clear cell carcinoma of the endometrium: potential diagnostic utility.

Tubal origin of ovarian endometriosis.

Biomarkers and endosalpingiosis in the ovarian and tubal microenvironment of women at high-risk for pelvic serous carcinoma.

Primary sources of pelvic serous cancer in patients with endometrial intraepithelial carcinoma.

Flutamide and biomarkers in women at high risk for ovarian cancer: preclinical and clinical evidence.

IMP3 signatures of fallopian tube: a risk for pelvic serous cancers.

Epidemiology of Functional abdominal bloating and its impact on health related quality of life: male-female stratified propensity score analysis in a population based survey in mainland China.

IMP3 as a cytoplasmic biomarker for early serous tubal carcinogenesis.

Tubal origin of ovarian low-grade serous carcinoma.

Effect of luteinizing hormone-induced prohibitin and matrix metalloproteinases on ovarian epithelial tumor cell proliferation.

Metalloprotease NleC suppresses host NF-κB/inflammatory responses by cleaving p65 and interfering with the p65/RPS3 interaction.

Tubal origin of ovarian endometriosis and clear cell and endometrioid carcinoma.

Keratin-dependent regulation of Aire and gene expression in skin tumor keratinocytes.

Ovarian serous carcinogenesis from tubal secretory cells.

Are clear cell carcinomas of the ovary and endometrium phenotypically identical? A proteomic analysis.

[Pathologic assessment and clinical impacts for endometrial cancer and precursors after progestin treatment].

Variants of human papillomavirus type 16 predispose toward persistent infection.

Primary alveolar rhabdomyosarcoma of fallopian tube masquerading as a unilateral adnexal mass: A case report and literature review.

Fallopian tube secretory cell expansion: a sensitive biomarker for ovarian serous carcinogenesis.

Pilot Clinical Evaluation of a Confocal Microlaparoscope for Ovarian Cancer Detection.

Mechanism of progestin resistance in endometrial precancer/cancer through Nrf2-AKR1C1 pathway.

Assessment of the Utility of PAX8 Immunohistochemical Stain in Diagnosing Endocervical Glandular Lesions.

Association between human papillomavirus type 16 E6 and E7 variants with subsequent persistent infection and recurrence of cervical high-grade squamous intraepithelial lesion after conization.

Assessment of the Role of Intraoperative Frozen Section in Guiding Surgical Staging for Endometrial Cancer.

Fallopian tube secretory cell expansion: a sensitive biomarker for ovarian serous carcinogenesis.

Clinical, biochemical and molecular analysis of two infants with familial chylomicronemia syndrome.

Overexpression and oncogenic function of HMGA2 in endometrial serous carcinogenesis.

Combination of radiotherapy and vaccination overcomes checkpoint blockade resistance.

Cytologic studies of the fallopian tube in patients undergoing salpingo-oophorectomy.

BRCA1 expression, proliferative and apoptotic activities in ovarian epithelial inclusions.

Mechanism of progestin resistance in endometrial precancer/cancer through Nrf2-survivin pathway.

Endometrial Carcinoma With Trophoblastic Components: Clinicopathologic Analysis of a Rare Entity.

Malignant Female Adnexal Tumor of Probable Wolffian Origin: Case Report and Literature Review.